Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma

Código QR

Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Chenhui Cai, Ying Zhang, Xu Hu, Wenhui Hu, Sizhen Yang, Hao Qiu, Tongwei Chu
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	CDT1 liver hepatocellular carcinoma prognostic value immune infiltration bioinformatics analysis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/e3485b5c89114f4ea6ea2b75f0fd9e9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Chenhui Cai, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Yumei Fan, et al.
Publicado: (2021)

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin T, et al.
Publicado: (2021)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Shuai Li, et al.
Publicado: (2021)

Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Luo Y, et al.
Publicado: (2021)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Shun Liu, et al.
Publicado: (2021)

A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
por: Qianqian Wu, et al.
Publicado: (2021)

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant <i>TP53</i> or Wild-Type <i>CTNNB1</i> Gene
por: Jiunn-Chang Lin, et al.
Publicado: (2021)

Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
por: Yongbiao Huang, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
por: Luo M, et al.
Publicado: (2021)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Junyu Huo, et al.
Publicado: (2021)

Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
por: Yuliang Sun, et al.
Publicado: (2021)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Rongqiang Liu, et al.
Publicado: (2021)

Carcinoma hepatocelular variedad fibrolamelar metastásico en menores de 20 años: Reporte de 2 casos tratados con intención curativa y revisión de la literatura
por: Butte,Jean M, et al.
Publicado: (2009)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Susu Zheng, et al.
Publicado: (2021)

The predictive role of preoperative serum glutamate dehydrogenase levels in microvascular invasion and hepatocellular carcinoma prognosis following liver transplantation—a single center retrospective study
por: Jinlong Gong, et al.
Publicado: (2021)

THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
por: Sri Budhi Rianawati, et al.
Publicado: (2021)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Shuang Liu, et al.
Publicado: (2021)

Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
por: Xiangdong Ye, et al.
Publicado: (2021)

Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma
por: Xiao-Wei Fu, et al.
Publicado: (2021)

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
por: Amira Isaac, et al.
Publicado: (2021)

A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
por: Jianhua Wu, et al.
Publicado: (2021)

Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
por: Zhijun Li, et al.
Publicado: (2021)

Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
por: He Aoxiao, et al.
Publicado: (2021)

Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer
por: Jiasui Wang, et al.
Publicado: (2021)

The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
por: Hiroaki Takaya, et al.
Publicado: (2021)

Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
por: Mei J, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo M, et al.
Publicado: (2021)

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
por: Liu X, et al.
Publicado: (2021)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Alice R. Owens, et al.
Publicado: (2021)

Seminal vesicle mass: An unusual site for metastatic hepatocellular carcinoma after orthotopic liver transplant
por: Diana A. Aponte-Colon, et al.
Publicado: (2022)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
por: Yu-Jie Xu, et al.
Publicado: (2021)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Hsin-Rou Liang, et al.
Publicado: (2021)

Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy
por: Jiamin Zhou, et al.
Publicado: (2021)

Association Between Procalcitonin and Post-hepatectomy Liver Failure in Hepatocellular Carcinoma Patients
por: Yi-Ran Li, et al.
Publicado: (2021)

Three-Device (3D) Technique for Liver Parenchyma Dissection in Robotic Liver Surgery
por: Aristotelis Perrakis, et al.
Publicado: (2021)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Hongsheng Lin, et al.
Publicado: (2021)

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
por: Tianhao Zhang, et al.
Publicado: (2021)

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
por: Danyang Zhou, et al.
Publicado: (2021)